Skip to main content
. 2021 Aug 1;17(8):1571–1578. doi: 10.5664/jcsm.9250

Table 1.

Comparison of patient demographic, clinical, and PSG data between groups.

Treated OSA (n = 13) Untreated OSA (n = 23) Treated IH/Narc (n = 12) P
Age (y) 53.8 ± 3.3 55.0 ± 2.8 36.1 ± 4.3* .001
Sex (% male) 85% 83% 42%* .019
BMI (kg/m2) 39.0 ± 1.9 30.4 ± 1.4 29.5 ± 2.6 .002
ESS 4.8 ± 1.0 6.3 ± 1.2 11.3 ± 1.6* .011
AHI (events/h) 9.6 ± 1.9 28.5 ± 5.6# 3.2 ± 0.7 .022
TST (minutes) 335.7 ± 20.2 347.5 ± 18.1 430.2 ± 11.1* .005

*Statistically significant difference in analysis of variance post hoc analysis between patients in the patients with treated IH/Narc compared to the treated OSA and untreated OSA groups. #Statistically significant difference between patients in the untreated OSA group compared to the treated OSA and treated IH/Narc groups. ^Statistically significant difference between patients in the treated OSA group compared to those in the untreated OSA group and the treated IH/Narc groups. AHI = apnea-hypopnea index, BMI = body mass index, ESS = Epworth Sleepiness Scare, IH = idiopathic hypersomnia, Narc = narcolepsy, OSA = obstructive sleep apnea, PSG = polysomnogram, TST = total sleep time.